#ppmdconference ผลการค้นหา

$PFE talking about anorexia.... told you so 😇 $SRPT #ppmdconference


And $PFE data presented today at #ppmdconference confirmed my earliest title: "Can Goliath ( $PFE) keep running after David ( $SRPT) or David will knock Goliath down & restore history "😎 And we have a clear winner $SRPT & the #DMD kids and their families 👏

I used "David vs. Goliath Can BLU Deliver A Better Chronic Cough Drug Than Merck?" for $BLUSF vs. $MRK headline. I will choose another headline for $SRPT: Can Goliath ( $PFE) keep running after David ( $SRPT) or David will knock Goliath down & restore history 😎



Drum rolls $PFE started $SRPT #ppmdconference


Aprovechando las pequeñas ventajas de esta nueva vida #online. Último día de la #ppmdconference. Always learning, always tuned. Thanks @parentprojectmd #dmd #enduchenne #eldesafiodepablo en Madrid, Spain instagram.com/p/CDEcG-DoRud/…


Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z #PPMDConference

Solid_Bio's tweet image. Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z

#PPMDConference

We are at @ParentProjectMD's 2019 Annual Conference. Be sure to check out our presentation tomorrow at 9:30am EST. #TogetherWeAreSolid #PatientPowered #PPMDConference

Solid_Bio's tweet image. We are at @ParentProjectMD's 2019 Annual Conference. Be sure to check out our presentation tomorrow at 9:30am EST. #TogetherWeAreSolid #PatientPowered #PPMDConference

Wow @TerriEllsworth is killing it with important questions to $PFE about AAV9 SAE 💯 $SRPT #PPMDCONFERENCE Billy is my #1


Matthew Klein from @PTCBio now presenting the results from their phase 3 clinical trial with ataluren during the late breaking news session @ParentProjectMD #PPMDConference

oligogirl's tweet image. Matthew Klein from @PTCBio now presenting the results from their phase 3 clinical trial with ataluren during the late breaking news session @ParentProjectMD #PPMDConference

What to do in an emergency? Session now at #PPMDConference with Sue Apkom. Sue stresses stress dosing multiple times @Bpn9211Brian @drjarodwong Note that detailed information for what to do in an emergency is available on the PPMD website and there is also an app!

oligogirl's tweet image. What to do in an emergency? Session now at #PPMDConference with Sue Apkom. Sue stresses stress dosing multiple times @Bpn9211Brian @drjarodwong Note that detailed information for what to do in an emergency is available on the PPMD website and there is also an app!
oligogirl's tweet image. What to do in an emergency? Session now at #PPMDConference with Sue Apkom. Sue stresses stress dosing multiple times @Bpn9211Brian @drjarodwong Note that detailed information for what to do in an emergency is available on the PPMD website and there is also an app!

As announced no #apaperaday today but instead highlights of the #PPMDconference in Phoenix that took place June 23-26 in Phoenix Arizona. It was the first in person meeting since 2019 and it was very good to meet people in 3D.

oligogirl's tweet image. As announced no #apaperaday today but instead highlights of the #PPMDconference in Phoenix that took place June 23-26 in Phoenix Arizona. It was the first in person meeting since 2019 and it was very good to meet people in 3D.

We are excited to announce that 5 industry partners will be presenting newly released data to the #Duchenne community for the first time during the Virtual #PPMDConference, June 23-26! parentprojectmd.org/ppmd-virtual-c…


$SRPT fully recruited it's microD pivotal study & $SLDB still presenting mouse data at #PPMDCONFERENCE !!!!


We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

Dyne_tx's tweet image. We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

La terza giornata #PPMDConference si apre con la sessione su #CRISPR, la celebre tecnica di #editing che sta cambiando il panorama della manipolazione genetica 🧬

franceradini's tweet image. La terza giornata #PPMDConference si apre con la sessione su #CRISPR, la celebre tecnica di #editing che sta cambiando il panorama della manipolazione genetica 🧬

Siblings with a brother or sister with #duchenne speak about family, sacrifice, service and love. @ParentProjectMD program helps families understand the needs of siblings too #ppmdconference


La seconda giornata della #ppmdconference si chiude con una sessione dedicata alle strategie di #exon #skipping. #duchenne #becker


Il Potere del linguaggio, una strategia per guardare oltre la patologia! #duchenne #becker #ppmdconference


@PepGentx enjoyed meeting and learning from the #Duchenne community at the #PPMDConference. Stay tuned here for a replay of our presentation. Thank you @ParentProjectMD

PepGenTx's tweet image. @PepGentx enjoyed meeting and learning from the #Duchenne community at the #PPMDConference.  Stay tuned here for a replay of our presentation. Thank you @ParentProjectMD

Our CMO @KreherNerissa shared our exon-skipping programs for people living with Duchenne who are exon 44 or exon 45 skip amenable @ParentProjectMD's conference. Thank you to all who participated, your insights are invaluable. #PPMDConference #DuchenneResearch #DMD

entradatx's tweet image. Our CMO @KreherNerissa shared our exon-skipping programs for people living with Duchenne who are exon 44 or exon 45 skip amenable @ParentProjectMD's conference. Thank you to all who participated, your insights are invaluable. #PPMDConference #DuchenneResearch #DMD

What a week! Thank you to our sponsors and everyone who joined us both in Dallas and virtually—#PPMDConference would not be such a fun-filled and impactful event year after year without you! parentprojectmd.org/catch-up-on-wh…

ParentProjectMD's tweet image. What a week! Thank you to our sponsors and everyone who joined us both in Dallas and virtually—#PPMDConference would not be such a fun-filled and impactful event year after year without you! parentprojectmd.org/catch-up-on-wh…

For those attending the #PPMDConference, stop by our photo booth in the Lone Star Foyer today. Come have your photo taken for the last day of the @ParentProjectMD 2023 Annual Conference. We look forward to seeing you!


This year’s Annual Conference brings together more than 1,000 families, researchers, clinicians, and industry partners from around the world—our largest Conference in PPMD history! Catch up on what's happening at the 2023 #PPMDConference with daily recaps: parentprojectmd.org/catch-up-on-wh…

ParentProjectMD's tweet image. This year’s Annual Conference brings together more than 1,000 families, researchers, clinicians, and industry partners from around the world—our largest Conference in PPMD history! Catch up on what's happening at the 2023 #PPMDConference with daily recaps: parentprojectmd.org/catch-up-on-wh…

Our CEO, Linda Marban sharing the most recent data from our HOPE-2 open label extension study at this year’s #PPMDConference. To view the webcast, please register at >>>>> bit.ly/448rqII. #PPMDconference #DMD #CAP1002 $CAPR

Capricor's tweet image. Our CEO, Linda Marban sharing the most recent data from our HOPE-2 open label extension study at this year’s #PPMDConference.
To view the webcast, please register at >>>>> bit.ly/448rqII.
#PPMDconference #DMD #CAP1002 $CAPR

We look forward to spending another productive day in Dallas at the @ParentProjectMD 2023 Annual Conference. Don’t forget to check out our fun photo booth in the Lone Star Foyer tomorrow! #PPMDConference

NSPharmaInc's tweet image. We look forward to spending another productive day in Dallas at the @ParentProjectMD 2023 Annual Conference. Don’t forget to check out our fun photo booth in the Lone Star Foyer tomorrow!  #PPMDConference

Capricor announces positive 24-month results from ongoing HOPE-2 open label extension study of CAP-1002 in Duchenne muscular dystrophy. Click here to view the press release bit.ly/44macre #PPMDconference #DMD #CAP1002 $CAPR

Capricor's tweet image. Capricor announces positive 24-month results from ongoing HOPE-2 open label extension study of CAP-1002 in Duchenne muscular dystrophy. Click here to view the press release bit.ly/44macre
#PPMDconference #DMD #CAP1002 $CAPR

We're at the #PPMDConference talking about our proof-of-concept data and upcoming Phase 2 study for WVE-N531, which we are investigating as a potential treatment to restore dystrophin in boys amenable to #exon53 skipping. Join us today in the Exon Skipping Strategies Session.

WaveLifeSci's tweet image. We're at the #PPMDConference talking about our proof-of-concept data and upcoming Phase 2 study for WVE-N531, which we are investigating as a potential treatment to restore dystrophin in boys amenable to #exon53 skipping. Join us today in the Exon Skipping Strategies Session.

We are in Dallas attending the @ParentProjectMD 2023 Annual Conference to share information, connect with families and hear about the latest developments. #Duchenne #PPMDConference #PPMD


Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z #PPMDConference

Solid_Bio's tweet image. Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z

#PPMDConference

The 2023 #PPMDConference is underway in Dallas, TX! Whether you're joining us in-person or virtually, we're so glad you're here. Psst...there's still time to register to tune in virtually! web.cvent.com/event/f695ea28…

ParentProjectMD's tweet image. The 2023 #PPMDConference is underway in Dallas, TX! Whether you're joining us in-person or virtually, we're so glad you're here. Psst...there's still time to register to tune in virtually! web.cvent.com/event/f695ea28…

Antisense Therapeutics Limited will be attending the 9th Annual Parent Project Muscular Dystrophy conference in Dallas, Texas USA. Dr Gil Price will present clinical data on ATL1102 and the recently initiated Phase IIb clinical trial. #Duchenne #MuscularDystrophy #PPMDConference

PercheronTxL's tweet image. Antisense Therapeutics Limited will be attending the 9th Annual Parent Project Muscular Dystrophy conference in Dallas, Texas USA. Dr Gil Price will present clinical data on ATL1102 and the recently initiated Phase IIb clinical trial. #Duchenne #MuscularDystrophy #PPMDConference

We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

Dyne_tx's tweet image. We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

The @ParentProjectMD Annual Conference is just around the corner. We are proud to be a sponsor of this year’s conference and look forward to connecting with families with #Duchenne. #PPMDConference #PPMD

NSPharmaInc's tweet image. The @ParentProjectMD Annual Conference is just around the corner. We are proud to be a sponsor of this year’s conference and look forward to connecting with families with #Duchenne. #PPMDConference #PPMD

We’re excited to sponsor @ParentProjectMD’s 2023 Annual Conference! Register to join us and the community at the conference, and be sure to visit our booth: bit.ly/3OoagSp #Duchenne #PPMDConference

Dyne_tx's tweet image. We’re excited to sponsor @ParentProjectMD’s 2023 Annual Conference! Register to join us and the community at the conference, and be sure to visit our booth: bit.ly/3OoagSp #Duchenne #PPMDConference

We're looking forward to @ParentProjectMD's Annual Conference in Dallas. This important event is a highlight for our team and we’re proud to be a Platinum sponsor. Join our Chief Medical Officer @KreherNerissa who will present on Friday! #PPMDconference

entradatx's tweet image. We're looking forward to @ParentProjectMD's Annual Conference in Dallas. This important event is a highlight for our team and we’re proud to be a Platinum sponsor. Join our Chief Medical Officer @KreherNerissa who will present on Friday! #PPMDconference

Prof Aartsma-Rus @oligogirl shares her highlights of the #PPMDConference by @ParentProjectMD taking place June 23-15 in Phoenix, AZ. 1️⃣ Late breaking news on trial results 2️⃣ Inclusion criteria in gene therapy trials 3️⃣ Overview of exon skipping trials worldduchenne.org/news/prof-aart…


ไม่พบผลลัพธ์สำหรับ "#ppmdconference"

We’re excited to sponsor @ParentProjectMD’s 2023 Annual Conference! Register to join us and the community at the conference, and be sure to visit our booth: bit.ly/3OoagSp #Duchenne #PPMDConference

Dyne_tx's tweet image. We’re excited to sponsor @ParentProjectMD’s 2023 Annual Conference! Register to join us and the community at the conference, and be sure to visit our booth: bit.ly/3OoagSp #Duchenne #PPMDConference

Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z #PPMDConference

Solid_Bio's tweet image. Solid Biosciences’ Nicoleta Stoicea, MD, PhD will be attending this year's @ParentProjectMD’s annual conference, where she will be participating in the Gene Therapy Town Hall on July 1 at 9:00am CT. View the schedule and register, here: bit.ly/3raiJ1Z

#PPMDConference

Day 2 of #PPMDConference starts with Ryan talking about patient focused drug development and the voice that matters - the voice of patients #wavelifesciences we agree!

wendy_erler's tweet image. Day 2 of #PPMDConference starts with Ryan talking about patient focused drug development and the voice that matters - the voice of patients #wavelifesciences we agree!
wendy_erler's tweet image. Day 2 of #PPMDConference starts with Ryan talking about patient focused drug development and the voice that matters - the voice of patients #wavelifesciences we agree!

We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

Dyne_tx's tweet image. We’re looking forward to the #PPMDConference. Register to watch our presentation on our investigational medicine, DYNE-251, being evaluated in the DELIVER clinical trial for people with #DMD with mutations amenable to exon 51 skipping: bit.ly/3OoagSp

Welcome to Day 4, the final day of the 2020 #PPMDConference – Virtual Edition! Join us today for important panel discussions on research and care, as well as our Keynote presentation and a look ahead to 2021. Agenda & register: parentprojectmd.org/conference

ParentProjectMD's tweet image. Welcome to Day 4, the final day of the 2020 #PPMDConference – Virtual Edition! Join us today for important panel discussions on research and care, as well as our Keynote presentation and a look ahead to 2021. Agenda & register: parentprojectmd.org/conference

Matthew Klein from @PTCBio now presenting the results from their phase 3 clinical trial with ataluren during the late breaking news session @ParentProjectMD #PPMDConference

oligogirl's tweet image. Matthew Klein from @PTCBio now presenting the results from their phase 3 clinical trial with ataluren during the late breaking news session @ParentProjectMD #PPMDConference

Beautiful comparison of all different types of ‘dystrophin producing’ therapies by Dongsheng Duong #ppmdconference

worldduchenne's tweet image. Beautiful comparison of all different types of ‘dystrophin producing’ therapies by Dongsheng Duong #ppmdconference

What a week! Thank you to our sponsors and everyone who joined us both in Dallas and virtually—#PPMDConference would not be such a fun-filled and impactful event year after year without you! parentprojectmd.org/catch-up-on-wh…

ParentProjectMD's tweet image. What a week! Thank you to our sponsors and everyone who joined us both in Dallas and virtually—#PPMDConference would not be such a fun-filled and impactful event year after year without you! parentprojectmd.org/catch-up-on-wh…

Don't miss this morning's Care Breakouts as part of the 2021 Virtual #PPMDConference. These smaller, interactive sessions will focus on specific care recommendations by age range. Register to attend at parentprojectmd.org/conference and join us with your questions at 11 AM EDT!

ParentProjectMD's tweet image. Don't miss this morning's Care Breakouts as part of the 2021 Virtual #PPMDConference. These smaller, interactive sessions will focus on specific care recommendations by age range. Register to attend at parentprojectmd.org/conference and join us with your questions at 11 AM EDT!

As announced no #apaperaday today but instead highlights of the #PPMDconference in Phoenix that took place June 23-26 in Phoenix Arizona. It was the first in person meeting since 2019 and it was very good to meet people in 3D.

oligogirl's tweet image. As announced no #apaperaday today but instead highlights of the #PPMDconference in Phoenix that took place June 23-26 in Phoenix Arizona. It was the first in person meeting since 2019 and it was very good to meet people in 3D.

#PPMDConference #TerapiaGenica Risultati molto promettenti di Sarepta: oltre 90% microdistrofina dopo 3 mesi di trattamento in 4 bambini. Ad oggi altri 12 pazienti sono stati trattati e l’azienda sta pianificando nuovo trial globale che includa anche ragazzi non deambulanti

franceradini's tweet image. #PPMDConference #TerapiaGenica Risultati molto promettenti di Sarepta: oltre 90% microdistrofina dopo 3 mesi di trattamento in 4 bambini. Ad oggi altri 12 pazienti sono stati trattati e l’azienda sta pianificando nuovo trial globale che includa anche ragazzi non deambulanti
franceradini's tweet image. #PPMDConference #TerapiaGenica Risultati molto promettenti di Sarepta: oltre 90% microdistrofina dopo 3 mesi di trattamento in 4 bambini. Ad oggi altri 12 pazienti sono stati trattati e l’azienda sta pianificando nuovo trial globale che includa anche ragazzi non deambulanti

It's the first day of the 2021 #PPMDConference – Virtual Edition! If you haven't yet registered, there's still time to do so! Visit parentprojectmd.org/conference to view the agenda and register.

ParentProjectMD's tweet image. It's the first day of the 2021 #PPMDConference – Virtual Edition! If you haven't yet registered, there's still time to do so! Visit parentprojectmd.org/conference to view the agenda and register.

Welcome to Day 2 of the 2020 #PPMDConference – Virtual Edition! Join us today for important panel discussions on research & care, as well as educational Lunch & Learn Breakout Sessions. Agenda & register: parentprojectmd.org/conference

ParentProjectMD's tweet image. Welcome to Day 2 of the 2020 #PPMDConference – Virtual Edition! Join us today for important panel discussions on research & care, as well as educational Lunch & Learn Breakout Sessions. Agenda & register: parentprojectmd.org/conference

Gene&Cell Therapy >> Published by Steve Hayes in Twitter: RT @Sarepta: Join us at the #PPMDConference this morning, where SRPT CEO, Doug Ingram,… dlvr.it/R7RgWS #LucidQuest #followthepatient #genetherapy #immunotherapy #celltherapy #cancer #biotech #regenerativemedicine

_timos_'s tweet image. Gene&Cell Therapy >> Published by Steve Hayes in Twitter: RT @Sarepta: Join us at the #PPMDConference this morning, where SRPT CEO, Doug Ingram,… dlvr.it/R7RgWS #LucidQuest #followthepatient #genetherapy #immunotherapy #celltherapy #cancer #biotech #regenerativemedicine

We are at @ParentProjectMD's 2019 Annual Conference. Be sure to check out our presentation tomorrow at 9:30am EST. #TogetherWeAreSolid #PatientPowered #PPMDConference

Solid_Bio's tweet image. We are at @ParentProjectMD's 2019 Annual Conference. Be sure to check out our presentation tomorrow at 9:30am EST. #TogetherWeAreSolid #PatientPowered #PPMDConference

Don't miss this afternoon's 2020 Virtual #PPMDConference Keynote: Language Shapes our Landscape (1:00 PM ET) with Rachel Callander. Rachel is a speaker, TEDx presenter, and the author of the internationally awarded book "Super Power Baby Project." Access: parentprojectmd.org/conference

ParentProjectMD's tweet image. Don't miss this afternoon's 2020 Virtual #PPMDConference Keynote: Language Shapes our Landscape (1:00 PM ET) with Rachel Callander. Rachel is a speaker, TEDx presenter, and the author of the internationally awarded book "Super Power Baby Project." 
Access: parentprojectmd.org/conference

Ready to present at #PPMDConference is #wavelifesciences CEO Paul Bolno sharing updates on Wave’s exon skipping programS!

wendy_erler's tweet image. Ready to present at #PPMDConference is #wavelifesciences CEO Paul Bolno sharing updates on Wave’s exon skipping programS!

Loading...

Something went wrong.


Something went wrong.